- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Schizophrenia
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Brexpiprazole – July 2025
Brexpiprazole; Tablet 500 micrograms; Rexulti®
Last updated
9 July 2025